Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data. - Erviti J; Wright J; Bassett K; Ben-Eltriki M; Jauca C; Saiz LC; Leache L; Gutiérrez-Valencia M; Perry TL (BMJ open, 2022)